30
Participants
Start Date
March 31, 2013
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Lofexidine HCl
Lofexidine HCl tablets titrated in ascending doses of 0.2 mg (1 tablet) QID starting at 0.4 mg (2 tablets) QID \[e.g. Day 1 0.4 mg (2 tablets) QID, Day 2 0.6 mg (3 tablets) QID, etc.\] as described in the treatment arm. Option to down-titrate to 0.2 mg (1 tablet) QID if 0.4 mg (2 tablets) QID dose not initially tolerated.
Lofexidine-matching sugar pill
Lofexidine-matching sugar pill tablets titrated in ascending doses of 1 tablet starting at 2 tablets QID (e.g. Day 1 2 tablets QID, Day 2 3 tablets QID, etc.) as described in the treatment arm. Option to down-titrate to 1 tablet QID if 2 tablets not initially tolerated.
Lifetree Clinical Research, Salt Lake City
National Institute on Drug Abuse (NIDA)
NIH
USWM, LLC (dba US WorldMeds)
INDUSTRY